ST Pharm Co.Ltd (237690) — Capital Reinvestment Ratio
ST Pharm Co.Ltd (237690) has a Capital Reinvestment Ratio of 0.50x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩29.25 Billion) in capital expenditures (₩14.61 Billion). Check ST Pharm Co.Ltd (237690) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ST Pharm Co.Ltd Capital Reinvestment Ratio (2015–2025)
This chart tracks ST Pharm Co.Ltd's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see 237690 cash flow metrics.
Annual Capital Reinvestment Ratio for ST Pharm Co.Ltd (2015–2025)
Year-by-year Capital Reinvestment Ratio for ST Pharm Co.Ltd from 2015 to 2025. See ST Pharm Co.Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 3.38x | ₩13.99 Billion | ₩47.29 Billion | ▲ +344.5% |
| 2024 | 0.76x | ₩109.45 Billion | ₩83.22 Billion | ▼ -97.7% |
| 2023 | 33.46x | ₩1.30 Billion | ₩43.44 Billion | ▲ +287.8% |
| 2022 | 8.63x | ₩7.03 Billion | ₩60.66 Billion | ▲ +21.1% |
| 2021 | 7.12x | ₩7.27 Billion | ₩51.79 Billion | ▲ +182.4% |
| 2018 | 2.52x | ₩10.77 Billion | ₩27.17 Billion | ▲ +395.9% |
| 2017 | 0.51x | ₩54.44 Billion | ₩27.70 Billion | ▲ +61.1% |
| 2016 | 0.32x | ₩50.78 Billion | ₩16.03 Billion | ▼ -49.5% |
| 2015 | 0.63x | ₩35.82 Billion | ₩22.40 Billion | — |